Gastrointestinal Cancers
32
10
11
10
Key Insights
Highlights
Success Rate
77% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
9.4%
3 terminated out of 32 trials
76.9%
-9.6% vs benchmark
9%
3 trials in Phase 3/4
20%
2 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (32)
Study to Assess the Efficacy and Safety of Rina-S in Participants With Advanced Gastrointestinal (GI) Cancers
A Randomized, Double-blind, Placebo-controlled, Prospective, Multi-center Trial Evaluating the Improvement of Nutritional Status and Sarcopenia With Silkworm Pupa Tablets in Patients With Malignancies
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
Personalized Health Self-Management Training for Colorectal Cancer Survivors
Feasibility Study of CBCT for IGRT in Cancer Patients
Evaluating a Bidirectional Priming Intervention for Goals-of-care Communication in Oncology
Frailty Scales for Predicting Chemotherapy Toxicity in Older Adults With Gastrointestinal Cancers
Clinical Evaluation of AI Decision Support for Early Rehabilitation After Surgery
Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers
Predicting Chemotherapy Toxicity Using FRAIL and FIND in Older Adults With Gastrointestinal Cancers
Predictive Value of Preoperative Rectus and Diaphragm Muscle Thickness for Postoperative Complications in Gastrointestinal Cancer Surgery
Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
Impact of Glycemic Variability on People With Gastrointestinal Cancer and Diabetes After Surgery
A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid Tumors
Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors
Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors
Sex Differences in Gastrointestinal Cancer Surgery
Ketamine-assisted Therapy for Advanced GI Cancer
Prophylactic or Preemptive Entecavir in Patients With Gastrointestinal Cancer Who Are Inactive Hepatitis B Carriers